Elite Semiconductor Microelectronics Technology Inc. (TPE:3006)

CTI BioPharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,437	4,485	4,520	4,765	9,791	3,598
Short-Term Investments	-	-	31.79	-	110.72	136.7
Trading Asset Securities	3.09	2.64	167.3	205.51	359.69	365.47
Cash & Short-Term Investments	4,440	4,488	4,719	4,970	10,261	4,100
Cash Growth	3.03%	-4.91%	-5.05%	-51.56%	150.27%	30.14%
Accounts Receivable	1,454	1,433	1,205	962.39	1,989	1,634
Other Receivables	178.21	121.58	340.24	304.94	116.46	95.83
Receivables	1,632	1,554	1,545	1,267	2,106	1,730
Inventory	7,773	7,937	6,886	8,369	5,376	5,969
Prepaid Expenses	603.73	902.88	399.67	444.56	69.11	27.6
Other Current Assets	0.51	0.26	2.86	0.82	0.17	5.2
Total Current Assets	14,449	14,882	13,552	15,052	17,812	11,832
Property, Plant & Equipment	1,935	1,942	2,033	2,128	1,376	857.38
Long-Term Investments	187.96	212.36	158.03	116.85	87.21	98.72
Goodwill	-	-	-	-	-	18.3
Other Intangible Assets	101.95	162.05	117.26	51.41	83.83	93.39
Long-Term Deferred Tax Assets	133.79	123.03	256.08	213.19	3.12	3.81
Other Long-Term Assets	227.75	349.86	1,981	2,164	875.42	96.7
Total Assets	17,036	17,672	18,097	19,726	20,237	13,000
Accounts Payable	2,238	2,386	2,285	2,328	2,983	2,398
Accrued Expenses	-	528.83	581.52	1,185	1,638	461.75
Short-Term Debt	2,100	1,600	2,620	3,175	1,700	1,490
Current Portion of Leases	23.3	23.26	13.91	12.88	11.5	10.36
Current Income Taxes Payable	26.18	2.33	1.3	3.46	911.14	147.95
Current Unearned Revenue	-	16.35	4.67	6.1	21.4	5.35
Other Current Liabilities	1,319	485.34	675.82	782.34	202.74	242.73
Total Current Liabilities	5,706	5,042	6,182	7,492	7,468	4,756
Long-Term Debt	1,880	2,012	1,586	643.4	-	-
Long-Term Leases	74.36	87.09	62.77	62.42	63.33	71.28
Long-Term Deferred Tax Liabilities	9.08	28.02	54.66	55.21	15.46	12.44
Other Long-Term Liabilities	212.21	208.77	283.06	26.07	24.38	20.66
Total Liabilities	7,882	7,384	8,177	8,288	7,578	4,871
Common Stock	2,862	2,862	2,862	2,862	2,862	2,858
Additional Paid-In Capital	510.47	503.99	487.27	255.32	181.33	109.68
Retained Earnings	6,099	7,188	6,854	8,591	9,840	5,437
Treasury Stock	-150.95	-140.06	-144.47	-147.7	-137.42	-145.65
Comprehensive Income & Other	-60.18	-27.78	-36.38	-46.31	-23.91	5.54
Total Common Equity	9,260	10,386	10,022	11,514	12,721	8,264
Minority Interest	-105.85	-98.6	-101.65	-76.45	-61.86	-134.76
Shareholders' Equity	9,154	10,287	9,920	11,438	12,660	8,129
Total Liabilities & Equity	17,036	17,672	18,097	19,726	20,237	13,000
Total Debt	4,078	3,723	4,283	3,894	1,775	1,571
Net Cash (Debt)	362.05	764.9	436.4	1,076	8,486	2,529
Net Cash Growth	-53.61%	75.28%	-59.46%	-87.31%	235.60%	-9.35%
Net Cash Per Share	1.29	2.61	1.56	3.83	30.07	8.99
Filing Date Shares Outstanding	280.67	273.17	272.76	272.45	272.8	271.61
Total Common Shares Outstanding	280.67	273.17	272.76	272.45	272.8	271.61
Working Capital	8,743	9,840	7,370	7,560	10,344	7,076
Book Value Per Share	32.99	38.02	36.74	42.26	46.63	30.43
Tangible Book Value	9,158	10,224	9,904	11,463	12,638	8,152
Tangible Book Value Per Share	32.63	37.43	36.31	42.07	46.32	30.02
Land	-	562.9	562.9	562.9	168.77	9.02
Buildings	-	1,076	1,089	1,086	732.85	636.45
Machinery	-	859.62	1,030	1,136	1,034	805.88

Source: S&P Global Market Intelligence. Standard template. Financial Sources.